Avicanna Inc
TSX:AVCN

Watchlist Manager
Avicanna Inc Logo
Avicanna Inc
TSX:AVCN
Watchlist
Price: 0.275 CAD 1.85% Market Closed
Market Cap: 31.4m CAD

Avicanna Inc
Investor Relations

Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario and currently employs 18 full-time employees. The company went IPO on 2019-07-18. The firm is engaged in cannabinoid research, development, and evidence-based products for the global consumer, as well as medical and pharmaceutical market segments. The firm's scientific platform commercializes over twenty products across four market segments: Medical Cannabis & Wellness Products, CBD Derma-Cosmetic Products, Pharmaceuticals and Cannabis Raw Materials, Seeds, and Bulk Formulations. Its Medical Cannabis & Wellness Products are an advanced line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC), marketed under the RHO Phyto brand. Its CBD Derma-Cosmetic Products are marketed under the Pura H&W or Pura Earth brands. Its cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.

Show more
Loading
AVCN
S&P TSX Composite Index (Canada)
1Y 3Y 5Y 10Y 15Y 20Y
Last Earnings Call
Fiscal Period
Q3 2023
Call Date
Nov 15, 2023
Q3 2023 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls
2023
Q3

Management

Mr. Aras Azadian B.Econ, Mba
Co-Founder, CEO & Director
No Bio Available
Mr. Phillip Cardella C.A., CPA
Chief Financial Officer
No Bio Available
Ms. Ivana Maric
Executive Vice President of Marketing
No Bio Available
Mr. Stephen Kim
Chief Legal Officer & General Counsel of Avicanna USA Inc.
No Bio Available
Dr. Karolina Urban
Executive Vice President of Scientific & Medical Affairs
No Bio Available
Mr. Arash Moghani MBA
Executive Vice President of Operations & Technology
No Bio Available
Ms. Ingrid Diaz
VP, Assistant General Counsel & Corporate Compliance Officer
No Bio Available
Mr. Enric Pujol
Vice President of People
No Bio Available
Dr. Carlos Enrique Maldonado Muete
SVP of Clinical Development
No Bio Available

Contacts

Address
ONTARIO
TORONTO
480 University Avenue, Suite 1502
Contacts
+16472435283.0
avicanna.com
sparklesyt

See Also

Summary
AVCN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AVCN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AVCN stock valuation using valuation multiples.
Wall Street Estimates
AVCN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AVCN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 287,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.